Thermal Burn clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Evaluation of the Effectiveness of PermeaDerm® (PD) as Compared to Mepilex Ag®
Sorry, not yet accepting patients
A total of 68 adult and pediatric patients who suffer from at least one discrete partial thickness thermal burn wound (Grade II) will be recruited. Subjects will be randomized (1:1) to either PermeaDerm® or Mepilex Ag®. Evaluations will occur at 7, 14 and 21 days with long term follow-up at 6 and 12 months.
at UC Davis
Our lead scientists for Thermal Burn research studies include David Greenhalgh, M.D..
Last updated: